PMDH3- THE USE OF SURROGATE ENDPOINT DATA IN EVALUATING TREATMENT EFFICACY- IMPACT ON DECISION-MAKING AND EXPENDITURE WITHIN THE AUSTRALIAN PHARMACEUTICAL BENEFITS SCHEME
Sep 1, 2000, 00:00 AM
10.1016/S1098-3015(11)70803-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)70803-8/fulltext
Section Title :
Section Order :
186
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70803-8&doi=10.1016/S1098-3015(11)70803-8